Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02345759
Other study ID # AWG 5/2014
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 2013
Est. completion date December 2020

Study information

Verified date August 2018
Source Anemia Working Group Romania
Contact Liliana Garneata, MD, PhD
Phone +40722619358
Email lilianagarna@yahoo.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Dietary management of CKD patients proved important to postpone dialysis. Long-term compliance to protein-restricted diets was discussed. Psychological aspects involved in certain dietary behaviour have never been studied.


Description:

The interest in dietary management resurged, since the high prevalence of revealed a major impact not only on morbidity, mortality, social activities and patients' quality of life, but also on health budget.

Although protein-restricted diets are used for more than a century in patients with advanced Chronic Kidney Disease (CKD), their efficacy and safety is still debatable. Enough evidence has being accumulated on their role in postponing dialysis initiation in compliant patients. Consequently, the long-term compliance to the diet is discussed. Psychological aspects of compliant patients are certainly involved. Identification of certain psychological predictors of dietary compliance could help to select the patients who are more likely to be compliant and therefore to benefit from such an intervention. Moreover, short-term or long-term psychological intervention addressing these factors could increase patient long-term compliance.

Accordingly, we are aiming to evaluate psychological characteristics of Chronic Kidney Disease patients in relation with their compliance to protein-restricted regimens.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date December 2020
Est. primary completion date September 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- adult patients

- stage 4+ CKD

- good nutritional status (Subjective Global Assessment score A/B and serum albumin =3.5 g/dL)

- declared potentially good compliance with a low protein diet and agreed to follow the monitoring schedule are considered for the program

Exclusion Criteria:

- poorly controlled arterial blood pressure (=145/85 mm Hg)

- uncontrolled diabetes mellitus

- other relevant comorbidities (heart failure, active hepatic disease, digestive diseases with malabsorption, inflammation/anti-inflammatory therapy)

- uremic complications (pericarditis, polyneuropathy)

- feeding inability (anorexia, nausea)

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Romania Spitalul Clinic de Nefrologie "Dr Carol Davila" Bucuresti

Sponsors (1)

Lead Sponsor Collaborator
Anemia Working Group Romania

Country where clinical trial is conducted

Romania, 

Outcome

Type Measure Description Time frame Safety issue
Other Safety parameters (Subjective Global Assessment, anthropometric markers, biochemical parameters, and serum total cholesterol) Parameters of nutritional status are predefined as safety parameters. Subjective Global Assessment anthropometric markers, and biochemical parameters 12 months
Primary Compliance to the protein-restricted diet The compliance to the diet is appreciated to be good if both the achieved protein intake and the achieved energy is in the range of ±10% of the recommended values. 12 months
Secondary Parameters related to renal function (The decline in glomerular filtration rate (GFR) GFR decline The decline in glomerular filtration rate (GFR) 12 months
Secondary Psychological parameter - self-efficacy score Self-efficacy score derives from the self-efficacy scale. 12 months
Secondary Nitrogen balance (Serum urea level) Serum urea level 12 months
Secondary Metabolic acidosis (Serum bicarbonate level) Serum bicarbonate level 12 months
Secondary Calcium-phosphorus metabolism abnormalities (Serum calcium) Serum calcium 12 months
Secondary Calcium-phosphorus metabolism abnormalities (Serum phosphates level) Serum phosphates level 12 months
Secondary Psychological parameter - illness perception (Sub-scores derived from illness perception questionnaire) Sub-scores derived from illness perception questionnaire: the higher this score, the worse is patient's perception on the disease. 12 months
Secondary Mental status - vitality index Vitality score derived from mental component of SF-36 12 months
Secondary Psychological parameter -mental score The mental score looks at depression. Psychological difficulties interfere with the initiation of compliance behaviours. 12 months